Your browser doesn't support javascript.
loading
Somatic MED12 mutations are associated with poor prognosis markers in chronic lymphocytic leukemia.
Kämpjärvi, Kati; Järvinen, Tiina M; Heikkinen, Tuomas; Ruppert, Amy S; Senter, Leigha; Hoag, Kevin W; Dufva, Olli; Kontro, Mika; Rassenti, Laura; Hertlein, Erin; Kipps, Thomas J; Porkka, Kimmo; Byrd, John C; de la Chapelle, Albert; Vahteristo, Pia.
Afiliação
  • Kämpjärvi K; Department of Medical Genetics and Genome-Scale Biology Research Program, University of Helsinki, Helsinki, Finland.
  • Järvinen TM; Department of Molecular Virology, Immunology and Medical Genetics, Division of Human Cancer Genetics, Comprehensive Cancer Center at The Ohio State University, Columbus, OH, USA.
  • Heikkinen T; Department of Medical Genetics and Genome-Scale Biology Research Program, University of Helsinki, Helsinki, Finland.
  • Ruppert AS; Department of Internal Medicine, Division of Hematology, Comprehensive Cancer Center at The Ohio State University, Columbus, OH, USA.
  • Senter L; Department of Molecular Virology, Immunology and Medical Genetics, Division of Human Cancer Genetics, Comprehensive Cancer Center at The Ohio State University, Columbus, OH, USA.
  • Hoag KW; Department of Molecular Virology, Immunology and Medical Genetics, Division of Human Cancer Genetics, Comprehensive Cancer Center at The Ohio State University, Columbus, OH, USA.
  • Dufva O; Department of Medical Genetics and Genome-Scale Biology Research Program, University of Helsinki, Helsinki, Finland.
  • Kontro M; Hematology Research Unit Helsinki, Department of Medicine, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland.
  • Rassenti L; Moores University of California-San Diego Cancer Center, University of California San Diego, CA, USA.
  • Hertlein E; Department of Internal Medicine, Division of Hematology, Comprehensive Cancer Center at The Ohio State University, Columbus, OH, USA.
  • Kipps TJ; Moores University of California-San Diego Cancer Center, University of California San Diego, CA, USA.
  • Porkka K; Hematology Research Unit Helsinki, Department of Medicine, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland.
  • Byrd JC; Department of Internal Medicine, Division of Hematology, Comprehensive Cancer Center at The Ohio State University, Columbus, OH, USA.
  • de la Chapelle A; Department of Molecular Virology, Immunology and Medical Genetics, Division of Human Cancer Genetics, Comprehensive Cancer Center at The Ohio State University, Columbus, OH, USA.
  • Vahteristo P; Department of Medical Genetics and Genome-Scale Biology Research Program, University of Helsinki, Helsinki, Finland.
Oncotarget ; 6(3): 1884-8, 2015 Jan 30.
Article em En | MEDLINE | ID: mdl-25595892
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Complexo Mediador Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Oncotarget Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Finlândia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Complexo Mediador Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Oncotarget Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Finlândia